Get Healthy!

New Study Suggests No Major Adverse Outcomes With Early GLP-1 Exposure During Pregnancy

Researchers found no substantial increase in the risk of pregnancy loss, abnormal fetal growth, or major congenital malformations among pregnancies with first-trimester GLP-1 exposure. But they say more studies are needed.

HealthDay
Health News is provided as a service to Colistics Pharmacy site users by HealthDay. Colistics Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2026 HealthDay All Rights Reserved.

Our commitment to patient care and health is priority one here at Colistics Pharmacy.

We believe in the value of providing personalized service and quality products.


Colistics Pharmacy
2901 General Degaulle Drive, Suite 101, New Orleans, LA 70114
(504) 361-5650 - (844) 230-5490
visa mastercard amex discover house